Scarica l'app Stockscreener
5.34
0.37%
-0.02
Dopo l'orario di chiusura:
5.32
-0.02
-0.37%
Precedente Chiudi:
$5.36
Aprire:
$5.36
Volume 24 ore:
586.75K
Relative Volume:
1.16
Capitalizzazione di mercato:
$1.20B
Reddito:
$596.48M
Utile/perdita netta:
$123.72M
Rapporto P/E:
9.7374
EPS:
0.5484
Flusso di cassa netto:
$106.59M
1 W Prestazione:
-0.37%
1M Prestazione:
-0.93%
6M Prestazione:
+50.42%
1 anno Prestazione:
+94.89%
Intervallo 1D:
$5.34
$5.36
Intervallo di 1 settimana:
$5.33
$5.38
Portata 52W:
$2.37
$5.72
Curevac N V Stock (CVAC) Company Profile
Confronta CVAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
5.34 | 1.21B | 596.48M | 123.72M | 106.59M | 0.5484 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-13 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-06-08 | Iniziato | SVB Securities | Outperform |
| 2023-01-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-01-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-01-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-10-22 | Iniziato | Deutsche Bank | Hold |
| 2021-06-17 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Underperform |
| 2021-04-26 | Iniziato | Guggenheim | Neutral |
| 2020-12-10 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-09-08 | Iniziato | BofA Securities | Buy |
| 2020-09-08 | Iniziato | Credit Suisse | Neutral |
| 2020-09-08 | Iniziato | Jefferies | Hold |
Mostra tutto
Curevac N V Borsa (CVAC) Ultime notizie
Using data tools to time your CureVac N.V. exitJuly 2025 Short Interest & Verified High Yield Trade Plans - newser.com
Historical volatility pattern of CureVac N.V. visualizedWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
How interest rate cuts could boost CureVac N.V. stockMarket Risk Summary & Weekly Momentum Stock Picks - newser.com
Will CureVac N.V. stock benefit from green energy trendsMarket Growth Report & Real-Time Volume Analysis - newser.com
Why CureVac N.V. stock is a value investor pickWeekly Trend Report & Verified Technical Trade Signals - newser.com
Can CureVac N.V. stock resist market sell offsRisk Management & Technical Confirmation Alerts - newser.com
Smart tools for monitoring CureVac N.V.’s price actionQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
How currency fluctuations impact CureVac N.V. stock2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com
Is CureVac N.V. stock positioned for digital transformation2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
CureVac’s New mRNA Study: A Potential Game-Changer in Lung Cancer Treatment - MSN
CureVac Announces Extraordinary Meeting for Merger with BioNTech - MSN
CureVac N.V. (NASDAQ:CVAC) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is CureVac N.V. stock supported by strong fundamentalsOptions Play & Safe Capital Growth Plans - Fundação Cultural do Pará
Analyzing net buyer seller activity in CureVac N.V.Options Play & Precise Trade Entry Recommendations - newser.com
Is CureVac N.V. stock ready for breakoutMarket Activity Report & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
CureVac schedules extraordinary shareholder meeting for November 25 By Investing.com - Investing.com South Africa
CureVac schedules extraordinary shareholder meeting for November 25 - Investing.com
CureVac schedules extraordinary meeting; releases proxy and merger docs - Stock Titan
Curevac N V Azioni (CVAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):